Common Contracts

Contract

May 5th, 2020

• Filed
  May 5th, 2020

EX-10.6 2 prta201610-kex106commercia.htm EXHIBIT 10.6 COMMERCIAL SUPPLY AGREEMENT WITH RENTSCHLER Confidential Treatment Requested by Prothena Corporation plc Exhibit 10.6 Commercial Supply Contract (the “Contract”) between Prothena Therapeutics Limited Adelphi Plaza Upper George's Street Dún Laoghaire Co. Dublin A96 T927 Ireland (“Customer”) and Rentschler Biotechnologie GmbH Erwin-Rentschler-Str. 21, 88471 Laupheim, Germany (“Rentschler”) each or together called the “Party/Parties”. WHEREAS, Rentschler and Customer have entered into a Master Development Services Agreement dated August 10, 2015 (the “MDSA”) for certain development and manufacturing services for clinical purposes for Customer’s Product (as defined below); WHEREAS, Rentschler and Customer entered into a non-binding Letter of Intent dated August 11, 2015, to set forth the Parties’ intentions in relation to the terms and conditions governing the commercial supply of Product; and WHEREAS, Customer desires to have Rentschle

Commercial Supply Contract

Prothena Corp PLC • February 27th, 2017 • Pharmaceutical preparations

• Company
  Prothena Corp PLC
• Filed
  February 27th, 2017
• Industry
  Pharmaceutical preparations

WHEREAS, Rentschler and Customer have entered into a Master Development Services Agreement dated August 10, 2015 (the “MDSA”) for certain development and manufacturing services for clinical purposes for Customer’s Product (as defined below);